中国医疗集团 2015 年报

中国医疗集团 2015 年报

中国医疗集团 2015 年报

CHARACTERISTICS OF THE GROWTH ENTERPRISE MARKET (“GEM”) OF

THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”)

GEM has been positioned as a market designed to accommodate companies to which a higher investment risk may be attached than other companies listed on the Stock Exchange. Prospective investors should be aware of the potential risks of investing in such companies and should make the decision to invest only after due and careful consideration. The greater risk profile and other characteristics of GEM mean that it is a market more suited to professional and other sophisticated investors.

Given the emerging nature of companies listed on GEM, there is a risk that securities traded on GEM may be more susceptible to high market volatility than securities traded on the Main Board of the Stock Exchange and no assurance is given that there will be a liquid market in the securities traded on GEM.

The Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this report, makes no representation as to its accuracy or completeness and expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this report.

This report, for which the directors (the “Directors”) of China Health Group Inc.(formerly known as Venturepharm Laboratories Limited)(the “Company”) collectively and individually accept full responsibility, includes particulars given in compliance with the Rules Governing the Listing of Securities on the Growth Enterprise Market of the Stock Exchange (the “GEM Listing Rules”) for the purpose of giving information with regard to China Health Group Inc. The Directors, having made all reasonable enquires, confirm that, to the best of their knowledge and belief: (1) the information contained in this report is accurate and complete in all material respects and not misleading; (2) there are no other matters the omission of which would make any statement in this report misleading; and (3) all opinions expressed in this report have been arrived at after due and careful consideration and are founded on bases and assumptions that are fair and reasonable.

?????????М??ǔ???ǔ?

?ˉ??ǔ?ˉ?ǔ????

創業板之定位, 乃為相比起其他在聯交所上市之公司帶有較高投資風險之公司提供一個上市之市場。有意投資之人士應瞭解投資於該等公司之潛在風險, 並應經過審慎周詳之考慮後方作出投資決定。創業板之較高風險及其他特色表示創業板較適合專業及其他資深投資者。

由於在創業板上市公司之新興性質所然, 在創業板買賣之證券可能會較於聯交所主機板買賣之證券承受較大之市場波動風險, 同時無法保證在創業板買賣之證券會有高流通量之市場。

香港交易及結算所有限公司及香港聯合交易所有限公司對本報告之內容概不負責, 對其準確性或完整性亦不發表任何聲明, 並明確表示概不就因本報告全部或任何部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。

本報告乃遵照聯交所創業板證券上市規則（「創業板上市規則」）之規定而提供有關中國醫療集團有限公司（前稱完全科技藥業有限公司）（「本公司」）之資料。中國醫療集團有限公司各董事（「董事」）對此共同及個別地承擔全部責任。董事在作出一切合理查詢後確認, 就彼等所知及深信：(1) 本報告所載資料在各重大方面均為準確及完整, 且並無誤導成份；(2) 本報告並無遺漏其他事項致使本報告所載任何內容有所誤導；及(3) 所有在本報告內表達之意見乃經過審慎周詳考慮後始行作出, 並以公平合理之基準及假設為依據。

中国医疗集团 2015 年报

?錄C O N T E N T S

公司资料 主席报告

财务摘要

管理层讨论及分析

董事及高级管理层简历

董事会报告 企业管治报告

獨立核數師報告書

綜合損失和其他全面收益表

综合财务状况表

综合权益变动表

综合现金流量表

财务报表附注 五年财务概要

................................................................................................................. 1Corporate Information

Chairman’s Statement

Financial Highlights

Management Discussion and Analysis

Profile of Directors and Senior Management

Directors’ Report

Corporate Governance Report

Independent Auditor's Report

Consolidated Statement of Profit or Loss and other Comprehensive Income Consolidated Statement of Financial Position

Consolidated Statement of Changes in Equity

Consolidated Statement of Cash Flows

Notes to the Financial Statements

Five Years Financial Summary

..................................................................................................................3................................................................................................................. 4..................................................................................................5..........................................................................................10..............................................................................................................12..........................................................................................................19...............................................................................................30...................................................................................33......................................................................................................34..............................................................................................................36......................................................................................................37......................................................................................................38.. (98)

中国医疗集团 2015 年报

中国医疗集团 2015 年报

中国医疗集团 2015 年报

尊敬的股東：

我們非常高興地向各位股東報告，醫療健康產業正成為中國成長最快機會最好的行業。借助中國醫療改革的挑戰與機會，中國醫療集團(「本集團」)正致力於打造成為一家互聯網架構下提供醫療終端綜合服務的集團公司，從醫院臨床研究與產品推廣服務、醫院管理服務、移動遠端醫療、特殊專科醫療到康復醫療和旅遊醫療服務的綜合醫療服務公司。

公司正在構築的四大成長引擎：

1.2.3.4.在財務經營方面，本集團也已經進入淨現金流為正的健康軌道。

總之，本集團已經從製藥服務技術企業全面轉型，進入了新型互聯網架構下的醫療大健康行業。中國醫療集團將利用十多年的經驗和專業累積，借力中國醫藥改革的歷史機會，為患者、員工和股東創造物質和精神的幸福價值。

受董事會委派William Xia Guo 主席

二零一六年三月十八日

醫院臨床研究與產品推廣服務：陽光萬全CRO，作為本集團之臨床研究與推廣旗艦，植根中國醫療15年，在國家臨床基地2000個中心建立起廣泛的專家關係和資源，通過上市後臨床研究，為企業提供科研和學術推廣服務。陽光萬全CRO通過構築治療領域專注的喜恩精神藥品臨床研究與推廣平臺、拜敏抗敏臨床研究與推廣平臺、卡地心血管臨床研究與推廣平臺、唐喜心血管臨床研究與推廣平臺，為新藥的臨床創新研究和製藥企業的學術推廣提供醫院綜合服務，並已簽訂多家合作合同。

醫院管理服務：本集團已經嘗試運行{中國大醫生}{我的醫生999}等移動互聯網的醫療和供藥服務，並開始籌建衛星移動醫療服務。

特殊專科醫療：目前已建立管理和並購團隊。

康復醫療和旅遊醫療服務：己經開始工作。

????

CHAIRMAN’S STATEMENT

DEAR SHAREHOLDERS:

We are very pleased to inform every one of you that health industry is developing to the industry with the fastest growing speed and best opportunity of all. With the help of challenge and opportunity provided by Chinese clinic revolution, China Health Group Inc. (the “Group”) is focusing on building itself into a group corporation providing comprehensive terminal medical service under international architecture, from hospital clinical research and product promotion service, hospital management service, mobile telemedicine service, special expertise therapy service to rehabilitation and medical tours service.

FOUR MAJOR ENGINES THE COMPANY IS CURRENTLY CONSTRUCTING:

1. 2.3.4.With Respect to financial operating area, the Group has already been on the healthy track of positive cash inflow.

In a word, the Group completed transiton from the type of pharmaceutical technology to new health care system under the new creative internet architecture. We will grasp the opportunity of the Chinese health care reform and take advantage of a more than ten years’ experience to creat physical and spritual welfare for the patients, staff and shareholders.By order of the Board William Xia Guo Chairman 18 March 2016

Hospital clinical research and product promotion service: Sunny venturepharma CRO, flagship of clinical research and product promotion service provider of the Group, rooting in Chinese health industry for 15 years, builds extensive relationship and resource based on its 2000 centers of clinical foundation over the country and provides research and academic promotion service through post market clinical studies. Through constructing clinical research and promotion platforms of therapy areas like CNS Psychotropic, Bye-Allergy Antianaphylaxis, CV Cardiovascular and Tangxi Cardiovascular , Sunny venturepharma CRO provides hospital comprehensive service to creative clinical research and academic promotion of pharmacy manufacturers and has signed several cooperation contracts.Hospital management service: the Group has tried to operate mobile Internet health care and drug delivery service like ‘Chinese best doctor’, ‘My doctor 999’, and currently is preparing for providing satellite mobile medical service.Special expertise therapy service: We have already begun to build management and M&A team for it.Projects related to rehabilitation therapy and medical tour service have been launched.

中国医疗集团 2015 年报

中国医疗集团 2015 年报

中国医疗集团 2015 年报

中国医疗集团 2015 年报

中国医疗集团 2015 年报

中国医疗集团 2015 年报

中国医疗集团 2015 年报

中国医疗集团 2015 年报

中国医疗集团 2015 年报

中国医疗集团 2015 年报

中国医疗集团 2015 年报

中国医疗集团 2015 年报

中国医疗集团 2015 年报

中国医疗集团 2015 年报

中国医疗集团 2015 年报

本文来源：https://www.bwwdw.com/article/7gs1.html